Universe Pharmaceuticals Inc. Class A Ordinary Shares (UPC) is a publicly traded Healthcare sector company. As of May 21, 2026, UPC trades at $2.76 with a market cap of $1.45M and a P/E ratio of 0.00. UPC moved +0.00% today. Year to date, UPC is -33.99%; over the trailing twelve months it is -55.22%. Its 52-week range spans $2.00 to $600.00. Rallies surfaces UPC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Universe Pharmaceuticals Effective Feb.13 Dual-Class Structure with 1.8B Class A, 200M Class B Shares: Universe Pharmaceuticals’ dual-class share structure becomes effective on February 13, 2026 after all implementation conditions were met. The amendment authorizes US$20,000 in share capital split into 1.8 billion Class A and 200 million Class B ordinary shares, with Class A continuing to trade under the UPC symbol.
| Metric | Value |
|---|---|
| Price | $2.76 |
| Market Cap | $1.45M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.33% |
| 52-Week High | $600.00 |
| 52-Week Low | $2.00 |
| Volume | 3 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
UPC analyst coverage data. Average price target: $0.00.